Resultados de la búsqueda 131-140 of 1750 for Off-label

  1. Nutrición y comida saludable Noticias de la Mayo Clinic

    enero 2025. Don't miss a quiet symptom of concussion Jan. 21, 2025, 05:00 p.m. CDT · Mayo Clinic Minute: New rule for 'healthy' food labels Jan. 20, 2025, 03 ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purposes of this study are (i) to obtain and study biospecimens from patients with breast cancer that has either spread out of the breast or recurred ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Venetoclax may stop the growth of cancer cells by blocking Bcl-2, a protein needed for cancer cell survival. Giving venetoclax with ibrutinib and rituximab with ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer cells in ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purposes of this study are (i) to obtain and study biospecimens from patients with breast cancer that has either spread out of the breast or recurred ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    A Phase I/II, open-label, multi-center trial of [177Lu]Lu-NeoB in combination with capecitabine in adult patients with GRPR+, ER+, HER2- metastatic breast ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This study aims to demonstrate acceptability and feasibility of the use of Distance Reiki therapy versus sham Reiki therapy among multiple myeloma patients.

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    A Phase I/II, open-label, multi-center trial of [177Lu]Lu-NeoB in combination with capecitabine in adult patients with GRPR+, ER+, HER2- metastatic breast ...

  9. Anaplastic large cell lymphoma - Diagnósticos y tratamientos - Mayo Clinic

    Find out more about the symptoms, diagnosis and treatment of this type of non-Hodgkin lymphoma.

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Acalabrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as obinutuzumab, may ...